# Shenqi Fuzheng Injection for the Treatment of Cancer-related Fatigue in Chemo Patients With Digestive Tract .

> **NCT03455205** · NA · UNKNOWN · sponsor: **Livzon Pharmaceutical Group Inc.** · enrollment: 270 (estimated)

## Conditions studied

- Digestive Tract

## Interventions

- **DRUG:** shenqifuzheng
- **DRUG:** 0.9%sodium chloride

## Key facts

- **NCT ID:** NCT03455205
- **Lead sponsor:** Livzon Pharmaceutical Group Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-24
- **Primary completion:** 2019-12-30
- **Final completion:** 2019-12-30
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2018-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03455205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03455205, "Shenqi Fuzheng Injection for the Treatment of Cancer-related Fatigue in Chemo Patients With Digestive Tract .". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03455205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*